Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Completion Of A Non-exclusive Discount Agreement According To Section 130a (8) Sgb V For The Active Ingredient Iron (parenteral Preparations), Atc B03ac01 F. D. Z. 01.11.25-31.10.27 (plus Extension Option 1x12 Month) 2026-03-15
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Follitropin Beta, Atc G03ga06 For The Time 01.11.2025 - 31.10.2027 2026-03-15
Germany Completion Of A Non-exclusive Discount Agreement According To Section 130a (8) Sgb V For The Active Ingredient Iron (parenteral Preparations), Atc B03ac01 F. D. Z. 01.11.25-31.10.27 (plus Extension Option 1x12 Month) 2026-03-15
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Follitropin Beta, Atc G03ga06 For The Time 01.11.2025 - 31.10.2027 2026-03-15
Germany Completion Of A Non-exclusive Discount Agreement According To Section 130a (8) Sgb V For The Active Ingredient Iron (parenteral Preparations), Atc B03ac01 F. D.z. 01.11.25-31.10.27 (plus Extension Option 1x12 Month) 2026-03-15
Germany Open House Pharmaceutical Dact Treaties For The Active Ingredient Clomipramin, Atc N06aa04 2026-03-15
Germany Open House Pharmaceutical Dact Treaties Timolol And Tafluprost, Atc S01ed70 2026-03-15
Germany Completion Of A Non-exclusive Discount Agreement According To Section 130a (8) Sgb V For The Active Ingredient Iron (parenteral Preparations), Atc B03ac01 F. D.z. 01.11.25-31.10.27 (plus Extension Option 1x12 Month) 2026-03-15
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Follitropin Beta, Atc G03ga06 For The Time 01.11.2025 - 31.10.2027 2026-03-15
Germany Pharmaceutical Discount Contracts In Accordance With Section 130a (8) Sgb V As Part Of Open House Procedures 2026-03-15
Whats app